SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-033047
Filing Date
2021-08-13
Accepted
2021-08-13 19:42:12
Documents
1
Period of Report
2021-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 18567
  Complete submission text file 0000899243-21-033047.txt   20258
Mailing Address 11 WESTCOTT ROAD PRINCETON NJ 08540
Business Address 11 WESTCOTT ROAD PRINCETON NJ 08540 650-477-8183
Consonance Life Sciences (Reporting) CIK: 0001824774 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39635 | Film No.: 211173969

Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Issuer) CIK: 0001824893 (see all company filings)

IRS No.: 981556622 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)